CN103798755A - 一种用于抗疲劳的胶囊 - Google Patents
一种用于抗疲劳的胶囊 Download PDFInfo
- Publication number
- CN103798755A CN103798755A CN201210439372.5A CN201210439372A CN103798755A CN 103798755 A CN103798755 A CN 103798755A CN 201210439372 A CN201210439372 A CN 201210439372A CN 103798755 A CN103798755 A CN 103798755A
- Authority
- CN
- China
- Prior art keywords
- american ginseng
- ginkgo biloba
- health food
- ferrous lactate
- fatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title abstract description 8
- 230000002929 anti-fatigue Effects 0.000 title abstract description 5
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 12
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 10
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 10
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 10
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 10
- 235000013402 health food Nutrition 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- -1 terpene lactone Chemical class 0.000 claims description 2
- 235000007586 terpenes Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 3
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract description 2
- 229940068052 ginkgo biloba extract Drugs 0.000 abstract description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229940126672 traditional medicines Drugs 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 241000218628 Ginkgo Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种用于抗疲劳的胶囊,活性成分及其重量含量是:银杏叶提取物40-80%、西洋参提取物25-50%、乳酸亚铁1-10%,余为辅料。本发明将银杏叶、西洋参等传统中药材与乳酸亚铁科学配伍,具有明显提高抗疲劳的效果,无明显副作用。
Description
技术领域
本发明涉及保健食品技术领域,具体涉及的是一种用于缓解体力疲劳的保健食品。
背景技术
现代医学认为疲劳是机体超限而引起的功能降低并出现机体不适的状态,主要表现为疲劳困倦,可出现头晕、健忘、睡眠质量下降等伴随症状。疲劳的产生与能源物质消耗、代谢产物堆积、内环境稳定性失调、自由基影响等因素关系密切。随着人们保健意识的加强,各种抗疲劳产品应运而生,其中中药类产品以其天然、安全、无毒副作用等优势,日益受到人们的关注,如虫草胶囊、西洋参片等。因此,开发具有中医特色的缓解体力疲劳的保健食品,不仅可以弥补现代医学在治疗上的不足,发挥中医中药的优势,而且其适宜人群范围广,市场需求大,具有广阔的市场前景。
发明内容
本发明的目的就是提供一种用于缓解体力疲劳的保健食品。不仅辨证组方,从根本上解决疲劳之根源,还结合了营养素、强化剂等能量物质,以促进体力恢复。
为了实现本发明目的,组成该保健食品的活性成分及其重量含量是:银杏叶提取物40-80%、西洋参提取物25-50%、乳酸亚铁1-10%,余为辅料。
本发明较优的原料配伍为:银杏叶提取物60%、西洋参提取物35%、乳酸亚铁5%,余为辅料。
本发明中银杏叶提取物含萜类内酯不少于5%;西洋参提取物总皂苷含量不少于5%。
与现有技术相比,本发明的优点是:辨证组方并结合营养素,疗效明确。
银杏叶:为银杏树的叶,主要成分为银杏黄酮。性味苦、涩,平。功能敛肺平喘,活血止痛。用于肺虚咳喘,以及高血脂、高血压、冠心病心绞痛、脑血管痉挛等。煎服5~10g,或制成片剂、注射剂。
西洋参:为五加科植物西洋参Panax quinquefolium L.的根。主产于美国、加拿大。我国北京、吉林、辽宁等地亦有栽培。秋季采挖生长3~6年的根,切片生用。西洋参有抗休克作用,能明显提高失血性休克大鼠存活率;对大脑有镇静作用,对生命中枢则有中度兴奋作用;还具抗缺氧、抗心肌缺血、抗心肌氧化、增加心肌收缩力、抗心律失常、抗疲劳、抗应激、抗惊厥、降血糖、止血和抗利尿作用。
乳酸亚铁:本品为铁元素补充剂。铁为血红蛋白及肌红蛋白的主要组成成分。血红蛋白为红细胞中主要携氧者,肌红蛋白系肌肉细胞贮存氧的部位,为肌肉运动时提供氧的需要。与三羧循环有关的大多数酶和因子均含铁,或仅在铁存在时才发挥作用。机体缺乏铁,可引起体力不足等。
具体实施方式
实施例1本发明胶囊剂的制备
银杏叶提取物60%、西洋参提取物35%、乳酸亚铁5%,余为辅料。
实施例2本发明胶囊剂的制备
银杏叶提取物74%、西洋参提取物25%、乳酸亚铁1%,余为辅料。
实施例3本发明胶囊剂的制备
银杏叶提取物40%、西洋参提取物50%、乳酸亚铁10%,余为辅料。
Claims (3)
1.一种用于缓解体力疲劳的保健食品,组成该保健食品的活性成分及其重量含量是:银杏叶提取物40-80%、西洋参提取物25-50%、乳酸亚铁1-10%,余为辅料。
2.如权利要求1所述的一种用于缓解体力疲劳的保健食品,其特征在于,组成该保健食品的活性成分及其重量含量是:银杏叶提取物60%、西洋参提取物35%、乳酸亚铁5%,余为辅料。
3.如权利要求1-2所述的一种用于缓解体力疲劳的保健食品,其特征在于,银杏叶提取物含萜类内酯不少于5%;西洋参提取物总皂苷含量不少于5%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210439372.5A CN103798755A (zh) | 2012-11-07 | 2012-11-07 | 一种用于抗疲劳的胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210439372.5A CN103798755A (zh) | 2012-11-07 | 2012-11-07 | 一种用于抗疲劳的胶囊 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103798755A true CN103798755A (zh) | 2014-05-21 |
Family
ID=50696526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210439372.5A Pending CN103798755A (zh) | 2012-11-07 | 2012-11-07 | 一种用于抗疲劳的胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103798755A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104041813A (zh) * | 2014-06-17 | 2014-09-17 | 史克勇 | 一种改善记忆保健品配方 |
CN104489651A (zh) * | 2014-11-27 | 2015-04-08 | 杨宪铭 | 一种以红景天、银杏叶和西洋参为活性成份的保健食品 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1237445A (zh) * | 1999-05-26 | 1999-12-08 | 胡小波 | 银杏洋参钙胶囊 |
KR20030073901A (ko) * | 2002-03-11 | 2003-09-19 | 박준희 | 영양식품물질 제조 방법 |
CN101468052A (zh) * | 2007-12-28 | 2009-07-01 | 李士俊 | 一种保健酒及其制备方法 |
CN101703545A (zh) * | 2009-09-29 | 2010-05-12 | 武征杰 | 银杏西洋参皂甙胶囊及其制备方法 |
CN102362881A (zh) * | 2011-10-31 | 2012-02-29 | 广西亿康药业股份有限公司 | 银杏洋参制剂的生产方法 |
-
2012
- 2012-11-07 CN CN201210439372.5A patent/CN103798755A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1237445A (zh) * | 1999-05-26 | 1999-12-08 | 胡小波 | 银杏洋参钙胶囊 |
KR20030073901A (ko) * | 2002-03-11 | 2003-09-19 | 박준희 | 영양식품물질 제조 방법 |
CN101468052A (zh) * | 2007-12-28 | 2009-07-01 | 李士俊 | 一种保健酒及其制备方法 |
CN101703545A (zh) * | 2009-09-29 | 2010-05-12 | 武征杰 | 银杏西洋参皂甙胶囊及其制备方法 |
CN102362881A (zh) * | 2011-10-31 | 2012-02-29 | 广西亿康药业股份有限公司 | 银杏洋参制剂的生产方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104041813A (zh) * | 2014-06-17 | 2014-09-17 | 史克勇 | 一种改善记忆保健品配方 |
CN104489651A (zh) * | 2014-11-27 | 2015-04-08 | 杨宪铭 | 一种以红景天、银杏叶和西洋参为活性成份的保健食品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101890040B (zh) | 一种具有抗疲劳作用的组合物及其应用 | |
TWI721248B (zh) | 提高耐力表現之抗疲勞組合物 | |
CN103798755A (zh) | 一种用于抗疲劳的胶囊 | |
CN102640826B (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN103564087A (zh) | 蛹虫草茶 | |
CN102669340B (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN102357208A (zh) | 一种治疗糖尿病、高血糖、高血压、高血脂的中药组合物 | |
CN101406644A (zh) | 一种具有降血糖作用的药物 | |
CN1686396A (zh) | 具有耐缺氧功能的保健品 | |
CN101637490A (zh) | 降压解脂、保肝护心、防癌抗衰老的中药 | |
CN103815482A (zh) | 仙鹤草饮料 | |
CN103798776A (zh) | 保健食品 | |
CN103417723A (zh) | 一种具有缓解体力疲劳功能的灵淫胶囊配方 | |
CN103800407A (zh) | 一种保健品组合物 | |
CN103349745A (zh) | 一种治疗糖尿病的中药汤剂 | |
CN102987005A (zh) | 一种益于糖尿病人服用的茶饮 | |
CN103798758A (zh) | 一种含有银杏叶提取物的制剂 | |
CN103798753A (zh) | 含有西洋参提取物的保健品 | |
CN111218370A (zh) | 一种具有抗疲劳功效的保健药酒及其制备方法 | |
CN103766884A (zh) | 一种新的复合制剂 | |
US20160058811A1 (en) | Composition for improving health and quality of life of women containing ginseng berry extract | |
CN103766888A (zh) | 一种含有西洋参提取物的制剂 | |
CN103766883A (zh) | 复方银杏叶提取物制剂 | |
CN103798757A (zh) | 一种功能性保健食品 | |
CN104161989A (zh) | 稳心竹苓菇酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140521 |